Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma

Background: Aggressive pancreatobiliary tumors often require oxaliplatin-based therapies, instead of standard gemcitabine-based therapy and biomarker studies at diagnosis to decide the appropriate therapeutic regimen. The ribonucleotide Reductase catalytic subunit M1 (RRM1) and excision repair cross...

Full description

Saved in:
Bibliographic Details
Main Authors: Khushbu Khetan, Ranjit K Sahoo, Vandana Baloda, Shalimar, Sreenivas Vishnubhatla, Anoop Saraya, Nihar Ranjan Dash, Atul Sharma, Siddhartha DattaGupta, Prasenjit Das
Format: article
Language:EN
Published: Wolters Kluwer Medknow Publications 2021
Subjects:
Online Access:https://doaj.org/article/0308f19bce6a47979b52fb9fb0ccd539
Tags: Add Tag
No Tags, Be the first to tag this record!